Calidi Biotherapeutics (CLDI) Misses Q1 EPS by 43c

Calidi Biotherapeutics (NYSE: CLDI) reported Q1 EPS of ($0.43).

For earnings history and earnings-related data on Calidi Biotherapeutics (CLDI) click here.

You May Also Be Interested In

• SanDisk upgraded at JPMorgan after investor day; shares climb
• Applied Industrial Technologies (AIT) PT Raised to $400 at DA Davidson
• BofA Securities Resumes American Eagle Outfitters (AEO) at Underperform